交易中 10-22 13:53:17 美东时间
-0.960
-1.27%
HC Wainwright & Co. analyst Mitchell Kapoor maintains Korro Bio (NASDAQ:KRRO) with a Buy and raises the price target from $100 to $115.
10-18 19:00
生物制药股WaVe生命科学隔夜涨74.1%;核能概念受热捧!资金竞相追逐,OKLO、NuScale隔夜暴涨超40%>>
10-17 19:35
U.S. stocks traded mostly higher toward the end of trading, with the Nasdaq Com...
09-18 02:31
U.S. stocks traded higher midway through trading, with the Dow Jones index gain...
09-18 00:16
An announcement from Korro Bio (KRRO) is now available. David L. Lucchino resig...
08-29 04:29
There's no doubt that money can be made by owning shares of unprofitable busine...
08-16 20:10
An update from Korro Bio (KRRO) is now available. Steve Colletti, Ph.D., has an...
06-22 05:14
加拿大蒙特利尔银行:维持Korro Bio(KRRO.US)评级,由优于大市调整至优于大市评级, 目标价120.00美元。
05-15 21:03
Korro Bio (NASDAQ:KRRO) reported quarterly losses of $(2.44) per share which beat the analyst consensus estimate of $(2.51) by 2.79 percent.
05-15 04:20
Biopharmaceutical company Korro Bio (NASDAQ:KRRO) entered into a subscription agreement with certain new and existing accredited investors to issue and sell an aggregate of ~1.25M shares in a private ...
04-18 20:50